EBRO 2017

Esophageal cancer: Neo-adjuvant Chemoradiotherapy or Chemotherapy?

EBRO 2017

Neo-adjuvant chemoradiotherapy: PLF x2 + 30 Gy + Cisplatin 50 mg/m 2 d1,8 + etop 80 mg/m 2 d3-5 RESECTION

R A N D O M

N=126

T3-4 N0-1 M0

Primary endpoint: 3-year overall survival

AC GEJ

Neo-adjuvant chemotherapy (PLF): Cisplatin 50 mg/m 2 bi-wk + 5FU 2 g/m 2 wk x2.5 RESECTION

Stahl et al. J Clin Oncol 2009